Since Commissioner Margaret Hamburg resigned in March, it has been speculated that Robert Califf could be the new US FDA commissioner. Califf has been with FDA since February in the role as depute commissioner for medical products and tobacco.
Going forward along with this new change, the Senate is currently working toward legislation to expedite FDA drug approval process. To read Zachary Brennan’s complete article, click here. Also check out the article in Medscape.